2-(azetidin-1-ylmethyl)-6-propan-2-ylpyrazine;2-(azetidin-1-ylmethyl)-4-propan-2-ylpyrimidine;3,4-dimethyl-5-propan-2-yl-1,2-oxazole;1,3-dimethyl-5-propan-2-ylpyrazole;2-methyl-5-propan-2-ylisoindole;2-methyl-5-propan-2-yl-1,3,4-oxadiazole;5-methyl-3-propan-2-yl-1,2-oxazole;1-methyl-3-propan-2-ylpyrazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;1-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxybutan-2-ol;2-propan-2-ylfuran;2-propan-2-yl-1H-imidazole;5-propan-2-yl-1H-imidazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;1-(6-propan-2-ylpyrazin-2-yl)oxybutan-2-ol;1-(4-propan-2-ylpyrimidin-2-yl)oxybutan-2-ol;2-propan-2-yl-1H-pyrrole;5-propan-2-yl-1H-1,2,4-triazole;1,3,5-trimethyl-4-propan-2-ylpyrazole
C170H273N37O12 — CID 158206831
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(azetidin-1-ylmethyl)-6-propan-2-ylpyrazine;2-(azetidin-1-ylmethyl)-4-propan-2-ylpyrimidine;3,4-dimethyl-5-propan-2-yl-1,2-oxazole;1,3-dimethyl-5-propan-2-ylpyrazole;2-methyl-5-propan-2-ylisoindole;2-methyl-5-propan-2-yl-1,3,4-oxadiazole;5-methyl-3-propan-2-yl-1,2-oxazole;1-methyl-3-propan-2-ylpyrazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;1-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxybutan-2-ol;2-propan-2-ylfuran;2-propan-2-yl-1H-imidazole;5-propan-2-yl-1H-imidazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;1-(6-propan-2-ylpyrazin-2-yl)oxybutan-2-ol;1-(4-propan-2-ylpyrimidin-2-yl)oxybutan-2-ol;2-propan-2-yl-1H-pyrrole;5-propan-2-yl-1H-1,2,4-triazole;1,3,5-trimethyl-4-propan-2-ylpyrazole
2-(azetidin-1-ylmethyl)-6-propan-2-ylpyrazine;2-(azetidin-1-ylmethyl)-4-propan-2-ylpyrimidine;3,4-dimethyl-5-propan-2-yl-1,2-oxazole;1,3-dimethyl-5-propan-2-ylpyrazole;2-methyl-5-propan-2-ylisoindole;2-methyl-5-propan-2-yl-1,3,4-oxadiazole;5-methyl-3-propan-2-yl-1,2-oxazole;1-methyl-3-propan-2-ylpyrazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;1-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxybutan-2-ol;2-propan-2-ylfuran;2-propan-2-yl-1H-imidazole;5-propan-2-yl-1H-imidazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;1-(6-propan-2-ylpyrazin-2-yl)oxybutan-2-ol;1-(4-propan-2-ylpyrimidin-2-yl)oxybutan-2-ol;2-propan-2-yl-1H-pyrrole;5-propan-2-yl-1H-1,2,4-triazole;1,3,5-trimethyl-4-propan-2-ylpyrazole (PubChem CID 158206831) has the molecular formula C170H273N37O12 and a molecular weight of 3027.30 g/mol. Its IUPAC name is 2-(azetidin-1-ylmethyl)-6-propan-2-ylpyrazine;2-(azetidin-1-ylmethyl)-4-propan-2-ylpyrimidine;3,4-dimethyl-5-propan-2-yl-1,2-oxazole;1,3-dimethyl-5-propan-2-ylpyrazole;2-methyl-5-propan-2-ylisoindole;2-methyl-5-propan-2-yl-1,3,4-oxadiazole;5-methyl-3-propan-2-yl-1,2-oxazole;1-methyl-3-propan-2-ylpyrazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;1-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxybutan-2-ol;2-propan-2-ylfuran;2-propan-2-yl-1H-imidazole;5-propan-2-yl-1H-imidazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;1-(6-propan-2-ylpyrazin-2-yl)oxybutan-2-ol;1-(4-propan-2-ylpyrimidin-2-yl)oxybutan-2-ol;2-propan-2-yl-1H-pyrrole;5-propan-2-yl-1H-1,2,4-triazole;1,3,5-trimethyl-4-propan-2-ylpyrazole.
Molecular Properties
| Compound Name | 2-(azetidin-1-ylmethyl)-6-propan-2-ylpyrazine;2-(azetidin-1-ylmethyl)-4-propan-2-ylpyrimidine;3,4-dimethyl-5-propan-2-yl-1,2-oxazole;1,3-dimethyl-5-propan-2-ylpyrazole;2-methyl-5-propan-2-ylisoindole;2-methyl-5-propan-2-yl-1,3,4-oxadiazole;5-methyl-3-propan-2-yl-1,2-oxazole;1-methyl-3-propan-2-ylpyrazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;1-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxybutan-2-ol;2-propan-2-ylfuran;2-propan-2-yl-1H-imidazole;5-propan-2-yl-1H-imidazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;1-(6-propan-2-ylpyrazin-2-yl)oxybutan-2-ol;1-(4-propan-2-ylpyrimidin-2-yl)oxybutan-2-ol;2-propan-2-yl-1H-pyrrole;5-propan-2-yl-1H-1,2,4-triazole;1,3,5-trimethyl-4-propan-2-ylpyrazole |
|---|---|
| PubChem CID | 158206831 |
| Molecular Formula | C170H273N37O12 |
| Molecular Weight | 3027.30 g/mol |
| Exact Mass | 3025.19 |
| IUPAC Name | 2-(azetidin-1-ylmethyl)-6-propan-2-ylpyrazine;2-(azetidin-1-ylmethyl)-4-propan-2-ylpyrimidine;3,4-dimethyl-5-propan-2-yl-1,2-oxazole;1,3-dimethyl-5-propan-2-ylpyrazole;2-methyl-5-propan-2-ylisoindole;2-methyl-5-propan-2-yl-1,3,4-oxadiazole;5-methyl-3-propan-2-yl-1,2-oxazole;1-methyl-3-propan-2-ylpyrazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;1-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxybutan-2-ol;2-propan-2-ylfuran;2-propan-2-yl-1H-imidazole;5-propan-2-yl-1H-imidazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;1-(6-propan-2-ylpyrazin-2-yl)oxybutan-2-ol;1-(4-propan-2-ylpyrimidin-2-yl)oxybutan-2-ol;2-propan-2-yl-1H-pyrrole;5-propan-2-yl-1H-1,2,4-triazole;1,3,5-trimethyl-4-propan-2-ylpyrazole |
| SMILES | CC(C)c1ccc2cn(C)cc2c1.CC(C)c1ccc[nH]1.CC(C)c1ccco1.CC(C)c1ccn(C)n1.CC(C)c1ccnc(CN2CCC2)n1.CC(C)c1ccnn1C.CC(C)c1cnc[nH]1.CC(C)c1cncc(CN2CCC2)n1.CC(C)c1cnco1.CC(C)c1cnn(C)c1.CC(C)c1ncc[nH]1.CC(C)c1ncco1.CC(C)c1ncn[nH]1.CCC(O)COc1cc(C)nc(C(C)C)n1.CCC(O)COc1cncc(C(C)C)n1.CCC(O)COc1nccc(C(C)C)n1.Cc1cc(C(C)C)n(C)n1.Cc1cc(C(C)C)no1.Cc1nn(C)c(C)c1C(C)C.Cc1nnc(C(C)C)o1.Cc1noc(C(C)C)c1C |
| InChI | InChI=1S/C12H20N2O2.C12H15N.2C11H17N3.2C11H18N2O2.C9H16N2.C8H14N2.C8H13NO.3C7H12N2.C7H11NO.C7H11N.C7H10O.C6H10N2O.2C6H10N2.2C6H9NO.C5H9N3/c1-5-10(15)7-16-11-6-9(4)13-12(14-11)8(2)3;1-9(2)10-4-5-11-7-13(3)8-12(11)6-10;1-9(2)10-4-5-12-11(13-10)8-14-6-3-7-14;1-9(2)11-7-12-6-10(13-11)8-14-4-3-5-14;1-4-9(14)7-15-11-6-12-5-10(13-11)8(2)3;1-4-9(14)7-15-11-12-6-5-10(13-11)8(2)3;1-6(2)9-7(3)10-11(5)8(9)4;1-6(2)8-5-7(3)9-10(8)4;1-5(2)8-6(3)7(4)9-10-8;1-6(2)7-4-8-9(3)5-7;1-6(2)7-4-5-9(3)8-7;1-6(2)7-4-5-8-9(7)3;1-5(2)7-4-6(3)9-8-7;2*1-6(2)7-4-3-5-8-7;1-4(2)6-8-7-5(3)9-6;1-5(2)6-3-7-4-8-6;1-5(2)6-7-3-4-8-6;1-5(2)6-3-7-4-8-6;1-5(2)6-7-3-4-8-6;1-4(2)5-6-3-7-8-5/h6,8,10,15H,5,7H2,1-4H3;4-9H,1-3H3;4-5,9H,3,6-8H2,1-2H3;6-7,9H,3-5,8H2,1-2H3;2*5-6,8-9,14H,4,7H2,1-3H3;6H,1-5H3;5-6H,1-4H3;5H,1-4H3;3*4-6H,1-3H3;4-5H,1-3H3;3-6,8H,1-2H3;3-6H,1-2H3;4H,1-3H3;2*3-5H,1-2H3,(H,7,8);2*3-5H,1-2H3;3-4H,1-2H3,(H,6,7,8) |
| InChIKey | GBPDZTRNRCCJAS-UHFFFAOYSA-N |
| XLogP | 39.27 |
| TPSA | 588.69 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 45 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 219 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3027.30 |
| LogP ≤ 5 | 39.27 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 45 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158206831 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.